Press Releases for the Psychedelics Industry | Page 17 of 37

Psychedelics News

Press Releases

8 Mar 2021

Pure Extracts Technologies Corp. Provides Update on Base Shelf Prospectus and Deemed Exercise of Special Warrants

Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States....

By Microdose

Press Releases

8 Mar 2021

Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

8 Mar 2021

Mindset Pharma Appoints Leading Molecular Pharmacologist & Formulation Expert Dr. Joseph Gabriele to Scientific Advisory Board

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

5 Mar 2021

MEC signs RTO definitive agreement to acquire Albert Labs, a European psychedelic drug researcher & developer

Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

4 Mar 2021

Tryp Therapeutics Announces Application to List on OTCQB

La Jolla, California–(Newsfile Corp....

By Microdose

Press Releases

4 Mar 2021

MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI™

CALGARY, AB, March 4, 2021 /CNW/ – MagicMed Industries Inc....

By Microdose

Press Releases

4 Mar 2021

PsyBio Therapeutics Announces Retention of Market Maker

TORONTO, March 04, 2021 (GLOBE NEWSWIRE) — PsyBio Therapeutics Corp....

By Microdose

Press Releases

4 Mar 2021

Regulatory approvals place Numinus lab at the forefront of global psychedelics research

Numinus Bioscience adds Ketamine and LSD to licence to produce, assemble and sell a wide variety of psychedelic compounds VANCOUVER, BC, March 4, 2021 /CNW/ - Numinus Wellness Inc....

By Microdose

Press Releases

4 Mar 2021

Pure Extracts Submits Dealer’s Licence Application to Health Canada

VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result